[Clinical guidelines for the diagnosis and treatment of chronic ulcerative colitis (CUC). Treatment of severe CUC and followup approach for cancer risk assessment].
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000150:complications / Q000601:surgery / Q000628:therapy*; D015179:Colorectal Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D000069285:Infliximab; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D012720:Severity of Illness Index
D000911:Antibodies, Monoclonal; D000069285:Infliximab